EBS
Emergent BioSolutions Inc.
Company Overview
| Mkt Cap | $438.01M | Price | $12.48 |
| Volume | 2.36M | Change | -2.80% |
| P/E Ratio | -2.3 | Open | $12.77 |
| Revenue | $1.0B | Prev Close | $12.84 |
| Net Income | $-190.6M | 52W Range | $4.02 - $13.41 |
| Div Yield | N/A | Target | $13.50 |
| Overall | 67 | Value | 60 |
| Quality | 42 | Technical | 100 |
No chart data available
Stock Overview
Updated DailyEmergent BioSolutions Inc. (EBS) is a leading Healthcare company in the Biotechnology industry, currently trading at $12.48 with a market capitalization of $438.01 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating below-average quality metrics with a MarketXLS quality score of 42.
Today's trading session shows EBS with a volume of 2.36 million shares. The stock opened down 0.55% from yesterday's close of $12.84. Current analyst estimates project earnings of $1.19 per share for this year, with next year targeting $-1.9.
EBS demonstrates very strong technical momentum based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including MRK, SIGA, XOMA, CMRX, GSK.
Key investment considerations for EBS include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 8.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:13 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EBS | $12.48 | -2.8% | 2.36M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Emergent BioSolutions Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW